![Edison Energy Serves as Technical Consultant for MSKCC's Radiation Oncology Cx Project | Edison Energy Edison Energy Serves as Technical Consultant for MSKCC's Radiation Oncology Cx Project | Edison Energy](https://uploads.edisonenergy.com/2017/12/EES_CaseStudy_MSKCC_RO_chart.png)
Edison Energy Serves as Technical Consultant for MSKCC's Radiation Oncology Cx Project | Edison Energy
![A Comparison of Predicted Ipsilateral Tumor Recurrence Risks in Patients With Ductal Carcinoma in Situ of the Breast After Breast-Conserving Surgery by Breast Radiation Oncologists, the Van Nuys Prognostic Index, the Memorial A Comparison of Predicted Ipsilateral Tumor Recurrence Risks in Patients With Ductal Carcinoma in Situ of the Breast After Breast-Conserving Surgery by Breast Radiation Oncologists, the Van Nuys Prognostic Index, the Memorial](https://ars.els-cdn.com/content/image/1-s2.0-S2452109420303109-gr2.jpg)
A Comparison of Predicted Ipsilateral Tumor Recurrence Risks in Patients With Ductal Carcinoma in Situ of the Breast After Breast-Conserving Surgery by Breast Radiation Oncologists, the Van Nuys Prognostic Index, the Memorial
Does Albumin Level Change the Strength of the Memorial Sloan Kettering Cancer Center Nomogram Used to Predict 5-year Survival in
![Performance of the American College of Surgeons NSQIP Surgical Risk Calculator for Total Gastrectomy Journal of the American College of Surgeons : December 2020 Performance of the American College of Surgeons NSQIP Surgical Risk Calculator for Total Gastrectomy Journal of the American College of Surgeons : December 2020](https://cdn.coverstand.com/58847/683188/article_assets/ce05f5c6646b17bbceebe09cd183722e975ca337.jpg)
Performance of the American College of Surgeons NSQIP Surgical Risk Calculator for Total Gastrectomy Journal of the American College of Surgeons : December 2020
![Updated Clinical Calculator Guides Treatment Plan for Rectal Cancer | Memorial Sloan Kettering Cancer Center Updated Clinical Calculator Guides Treatment Plan for Rectal Cancer | Memorial Sloan Kettering Cancer Center](https://www.mskcc.org/sites/default/files/styles/large/public/node/260526/3x2/weiser_clinic_180831_148_1200x800.jpg)
Updated Clinical Calculator Guides Treatment Plan for Rectal Cancer | Memorial Sloan Kettering Cancer Center
![Predicting the likelihood of additional lymph node metastasis in sentinel lymph node positive breast cancer: validation of the Memorial Sloan-Kettering Cancer Centre (MSKCC) nomogram | Journal of Clinical Pathology Predicting the likelihood of additional lymph node metastasis in sentinel lymph node positive breast cancer: validation of the Memorial Sloan-Kettering Cancer Centre (MSKCC) nomogram | Journal of Clinical Pathology](https://jcp.bmj.com/content/jclinpath/67/2/112/F3.large.jpg)
Predicting the likelihood of additional lymph node metastasis in sentinel lymph node positive breast cancer: validation of the Memorial Sloan-Kettering Cancer Centre (MSKCC) nomogram | Journal of Clinical Pathology
![Cancers | Free Full-Text | Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390 Cancers | Free Full-Text | Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390](https://www.mdpi.com/cancers/cancers-12-00808/article_deploy/html/images/cancers-12-00808-g001.png)
Cancers | Free Full-Text | Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390
![External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imaging - Soeterik - External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imaging - Soeterik -](https://bjui-journals.onlinelibrary.wiley.com/cms/asset/9d5ee1fb-33f1-48da-924c-36a2e1471e12/bju15376-fig-0002-m.jpg)
External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imaging - Soeterik -
![Multicenter prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: the MSKCC nomogram and Multicenter prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: the MSKCC nomogram and](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2017.47/MediaObjects/41416_2017_Article_BFbjc201747_Fig1_HTML.jpg)
Multicenter prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: the MSKCC nomogram and
![Evaluation of Memorial Sloan‐Kettering Cancer Center and International Extranodal Lymphoma Study Group prognostic scoring systems to predict Overall Survival in intracranial Primary CNS lymphoma - Jahr - 2018 - Brain and Behavior - Evaluation of Memorial Sloan‐Kettering Cancer Center and International Extranodal Lymphoma Study Group prognostic scoring systems to predict Overall Survival in intracranial Primary CNS lymphoma - Jahr - 2018 - Brain and Behavior -](https://onlinelibrary.wiley.com/cms/asset/645438e5-35c6-473b-84f4-8e56b85a422a/brb3928-toc-0001-m.jpg?trick=1678042845690)